Research Reference Library · Educational Use Only

GHK-Cu for Hair Regrowth: Topical vs Injectable — What the Research Shows

Last reviewed 2025 · Focus: ghk-cu dosage hair regrowth · Source: peer-reviewed preclinical literature

GHK-Cu and the Hair Follicle

GHK-Cu (glycine-histidine-lysine copper complex) has been studied since the 1970s for its tissue-regenerative properties. Its relevance to hair regrowth stems from its ability to stimulate follicle stem cell proliferation, upregulate vascular endothelial growth factor (VEGF), and inhibit DHT-induced miniaturisation of follicles — the primary driver of androgenetic alopecia.

Topical Application

Topical GHK-Cu is the most widely studied route for hair applications. Concentrations ranging from 0.1% to 2% have been tested, with dermal penetration enhanced by microchanneling or minoxidil co-application. A 2018 study published in International Journal of Molecular Sciences demonstrated upregulation of 4,000+ genes relevant to skin repair and hair follicle maintenance.

Injectable Protocol in Research

Injectable GHK-Cu is used in preclinical scalp injection research at 100–200 mcg per session, 2–3 times weekly for 8–12 weeks. Mesotherapy protocols in European dermatology research have used similar ranges.

Research-grade GHK-Cu (50 mg and 200 mg vials) available at QSC Peptides with HPLC COA.

Research-grade peptides with HPLC-verified COA
All compounds referenced in this guide are available at QSC Peptides (qscpeptide.com) — US domestic warehouse, fast shipping, batch-level certificates of analysis.

This page is for educational and research purposes only. All products sold by QSC are labelled for research use only and are not intended for human consumption. Nothing on this page constitutes medical advice.